long-term treatment [hlca]
Growth Hormone [aapp, horm, phsu]
Decrease [qlco]
Plasminogen Activator [aapp, enzy, phsu]
Tissue Plasminogen Activator [aapp, enzy, phsu]
Growth Hormone [aapp, horm, phsu]
Deficient [ftcn]
Adults [aggp]
Syndrome [dsyn]
Growth hormone deficiency [dsyn]
Adults [aggp]
Associated [qlco]
Premature [tmco]
Atherosclerosis [dsyn]
Increased [qnco]
CARDIOVASCULAR [bdsy]
Mortality [qnco]
Abnormal [qlco]
Lipoprotein pattern [clna]
Abnormal [qlco]
Body Composition [orga]
Show [inpr]
GH [aapp, enzy]
Deficient [ftcn]
Adults [aggp]
Increased [qnco]
Concentrations [menp]
Fibrinogen [aapp, bacs, phsu]
plasminogen activator activity [moft]
Inhibitor [qlco]
Aim [idcn]
Present [qnco]
Investigation [hlca]
To [qlco]
Study [mnob]
Coagulation [ortf]
Fibrinolysis [phsf]
Patients [podg]
Adult-onset growth hormone deficiency [dsyn]
Two [qnco]
treatment [ftcn]
Recombinant GH [aapp, horm, phsu]
Human [humn]
MU/day [qnco]
g/kg body weight [qnco]
IMPACT [gngm]
Metabolic [ftcn]
variables [qlco]
Body Composition [orga]
Coagulation [ortf]
Fibrinolysis [phsf]
Study [mnob]
Patients [podg]
Received [qlco]
Conventional [qlco]
Thyroid, NOS [bpoc]
Gonadal [bpoc]
Hormone replacement therapy [topp]
Pai [idcn]
I- [inch]
activity [dora]
Plasminogen activator inhibitor antigen [imft]
Tissue Plasminogen Activator Antigen [imft]
Level [qlco]
Decreased [qnco]
GB [geoa]
treatment [ftcn]
P NOS [aapp, imft]
Decrease [qlco]
More [ftcn]
Patients [podg]
High [qlco]
pre treatment [tmco]
Level [qlco]
Different [qlco]
variables [qlco]
Decreased [qnco]
P NOS [aapp, imft]
Plasminogen [aapp, bacs, phsu]
Unchanged [fndg]
Two [qnco]
GH [aapp, enzy]
treatment [ftcn]
Fibrinogen [aapp, bacs, phsu]
Concentrations [menp]
To [qlco]
Decrease [qlco]
Two [qnco]
GN [geoa]
treatment [ftcn]
P NOS [aapp, imft]
Coagulation Factor VII [aapp, bacs, phsu]
VIII [inpr]
Unchanged [fndg]
von Willebrand Factor [aapp, bacs, phsu]
Transient [popg]
Decrease [qlco]
months [tmco]
GH [aapp, enzy]
treatment [ftcn]
Coagulation [ortf]
Inhibitor [qlco]
Protein C [aapp, bacs, phsu]
Decreased [qnco]
P NOS [aapp, imft]
Antithrombin [aapp, phsu]
Unchanged [fndg]
Fasting [fndg]
plasma insulin [lbpr]
Increased [qnco]
P NOS [aapp, imft]
Blood Glucose [carb]
Not [ftcn]
Two [qnco]
GH [aapp, enzy]
treatment [ftcn]
serum high density lipoprotein [lbpr]
Cholesterol [bacs, strd]
Total Cholesterol [lbpr]
Triglycerides [bacs, lipd]
Unaltered [qlco]
body [humn]
HI [geoa]
Decreased [qnco]
Initial [tmco]
GH [aapp, enzy]
treatment [ftcn]
Unaltered [qlco]
Two [qnco]
Lean body mass [clna]
Increased [qnco]
P NOS [aapp, imft]
Waist [blor]
Hip circumference [clna]
Ratio [qnco]
To [qlco]
Decrease [qlco]
P NOS [aapp, imft]
Conclusion [idcn]
plasminogen activator activity [moft]
Inhibitor [qlco]
Plasminogen activator inhibitor antigen [imft]
Tissue Plasminogen Activator Antigen [imft]
Decreased [qnco]
long-term treatment [hlca]
GH [aapp, enzy]
Direct [qlco]
Effect [qlco]
GH [aapp, enzy]
secondary [neop]
Favorable [qlco]
AES [gngm]
Body Composition [orga]
To [qlco]
Seen [qlco]
fibrinolytic [topp]
variables [qlco]
rhGH [aapp, horm, phsu]
treatment [ftcn]
CARDIOVASCULAR [bdsy]
Risk [qlco]
Patients [podg]
Growth hormone deficiency [dsyn]
Present [qnco]
Result [ftcn]
Suggest [idcn]
GH [aapp, enzy]
Play [dora]
Role [socb]
Regulation [gora]
Fibrinolysis [phsf]
